In a significant stride toward revolutionizing the pharmaceutical industry, Ceremorphic Life Sciences, a company founded by Venkat Mattela in April 2020, has announced the development of a cutting-edge drug development platform, BioCompDiscoverX. The platform harnesses the power of analog and artificial intelligence (AI) processing technology, offering potential savings amounting to billions of dollars for the ... Read more